Page 186 - Comprehensive treatment of patients with glucocorticoid-dependent severe asthma

Appendix
6. The burden of severe asthma in childhood and adolescence: results from the paediatric U-BIOPRED cohorts.
Fleming L, Murray C, Bansal AT, Hashimoto S, Bisgaard H, Bush A, Frey U, Hedlin G, Singer F, van Aalderen WM, Vissing NH, Zolkipli Z, Selby A, Fowler S, Shaw D, Chung KF, Sousa AR, Wagers S, Corfield J, Pandis I, Rowe A, Formaggio E, Sterk PJ, Roberts G; U-BIOPRED Study Group.
Eur Respir J. 2015;46(5):1322-33.
7. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort.
Shaw DE, Sousa AR, Fowler SJ, Fleming LJ, Roberts G, Corfield J, Pandis I, Bansal AT, Bel EH, Auffray C, Compton CH, Bisgaard H, Bucchioni E, Caruso
M, Chanez P, Dahlén B, Dahlen SE, Dyson K, Frey U, Geiser T, Gerhardsson de Verdier M, Gibeon D, Guo YK, Hashimoto S, Hedlin G, Jeyasingham E, Hekking PP, Higenbottam T, Horváth I, Knox AJ, Krug N, Erpenbeck VJ, Larsson LX, Lazarinis N, Matthews JG, Middelveld R, Montuschi P, Musial J, Myles D, Pahus L, Sandström T, Seibold W, Singer F, Strandberg K, Vestbo J, Vissing N, von Garnier C, Adcock IM, Wagers S, Rowe A, Howarth P, Wagener AH, Djukanovic R, Sterk PJ, Chung KF; U-BIOPRED Study Group.
Eur Respir J. 2015;46(5):1308-21.
8. Anxiety, depression and personality traits in severe, prednisone-dependent asthma.
Hashimoto S, Amelink M, Spinhoven P, Pasma HR, Sterk PJ, Bel EH, ten Brinke A. Respir Med. 2014;108(3):438-44.
9. Targeting IL-5 in severe asthma: a DREAM come true? Hashimoto S, Bel EH.
Lancet. 2012;380(9842):626-7.
10. Telemanagement in asthma: an innovative and effective approach. van Gaalen JL, Hashimoto S, Sont JK.
Curr Opin Allergy Clin Immunol. 2012;12(3):235-40.
184